Dianthus Therapeutics (DNTH) EPS (Weighted Average and Diluted): 2022-2025
Historic EPS (Weighted Average and Diluted) for Dianthus Therapeutics (DNTH) over the last 3 years, with Sep 2025 value amounting to -$0.97.
- Dianthus Therapeutics' EPS (Weighted Average and Diluted) fell 31.08% to -$0.97 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.49, marking a year-over-year decrease of 148.74%. This contributed to the annual value of -$2.55 for FY2024, which is 69.82% up from last year.
- Latest data reveals that Dianthus Therapeutics reported EPS (Weighted Average and Diluted) of -$0.97 as of Q3 2025, which was down 10.23% from -$0.88 recorded in Q2 2025.
- Over the past 5 years, Dianthus Therapeutics' EPS (Weighted Average and Diluted) peaked at $8.95 during Q4 2023, and registered a low of -$12.73 during Q2 2023.
- In the last 3 years, Dianthus Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.82 in 2025 and averaged -$1.90.
- As far as peak fluctuations go, Dianthus Therapeutics' EPS (Weighted Average and Diluted) surged by 177.36% in 2023, and later slumped by 109.16% in 2024.
- Dianthus Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$11.57 in 2022, then skyrocketed by 177.36% to $8.95 in 2023, then slumped by 109.16% to -$0.82 in 2024, then crashed by 31.08% to -$0.97 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.97 in Q3 2025, compared to -$0.88 in Q2 2025 and -$0.82 in Q1 2025.